To investigate the role of GalNAc glycosylation in vivo for this MUC1 model tumor antigen, we immunized Balb/c mice and HLA-A2 transgenic mice with degMUC1 with and without GalNAc glycosylation. The gene discussed is MUC1; the disease is neoplasm.